3 The procedure

3 The procedure

3.1 The procedure is done with the patient under general anaesthesia and using imaging guidance including fluoroscopy, angiography and transoesophageal echocardiography. Prophylactic antibiotics and anticoagulants are given before and during the procedure. Temporary peripheral extracorporeal circulatory support (usually through the femoral vessels) is sometimes used.

3.2 The mitral valve is accessed surgically via apical puncture of the left ventricle using an anterior or left lateral minithoracotomy (transapical approach). A guidewire is placed across the existing mitral prosthetic valve and into a pulmonary vein. A balloon catheter delivery system is then advanced over the guidewire. When there is severe prosthetic mitral valve stenosis, a balloon valvuloplasty may be done first. The inner diameter of the degenerated valve is measured using transoesophageal echocardiography to establish the size of new bioprosthetic valve needed. Using the delivery system, the new bioprosthetic valve is then introduced, manipulated into position and slowly deployed within the degenerated mitral valve under fluoroscopic and echocardiographic guidance. Often, rapid ventricular pacing is used to reduce movement of the heart. After valve deployment, the catheter delivery system, guidewires and pacing wires are removed and the chest wound is closed. Valve performance is then assessed using echocardiography and fluoroscopy.

  • National Institute for Health and Care Excellence (NICE)